Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immune Checkpoint Inhibitors: New Weapons Against Medullary Thyroid Cancer?
Di Molfetta S, Dotto A, Fanciulli G, Florio T, Feola T, Colao A, Faggiano A. Di Molfetta S, et al. Among authors: dotto a. Front Endocrinol (Lausanne). 2021 Apr 14;12:667784. doi: 10.3389/fendo.2021.667784. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33935977 Free PMC article. Review.
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective.
Muscogiuri G, Altieri B, Albertelli M, Dotto A, Modica R, Barrea L, Fanciulli G, Feola T, Baldelli R, Ruggeri RM, Gallo M, Guarnotta V, Malandrino P, Messina E, Venneri MA, Giannetta E, Ferone D, Colao A, Faggiano A; NIKE group. Muscogiuri G, et al. Among authors: dotto a. Endocrine. 2020 Aug;69(2):441-450. doi: 10.1007/s12020-020-02331-3. Epub 2020 May 28. Endocrine. 2020. PMID: 32468269
PRRT: identikit of the perfect patient.
Albertelli M, Dotto A, Di Dato C, Malandrino P, Modica R, Versari A, Colao A, Ferone D, Faggiano A; NIKE. Albertelli M, et al. Among authors: dotto a. Rev Endocr Metab Disord. 2021 Sep;22(3):563-579. doi: 10.1007/s11154-020-09581-6. Rev Endocr Metab Disord. 2021. PMID: 32978685 Free PMC article. Review.
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study.
Massironi S, Campana D, Pusceddu S, Albertelli M, Faggiano A, Panzuto F, Smiroldo V, Andreasi V, Rossi RE, Maggio I, Torchio M, Dotto A, Modica R, Rinzivillo M, Carnaghi C, Partelli S, Fanetti I, Lamberti G, Corti F, Ferone D, Colao A, Annibale B, Invernizzi P, Falconi M; ItaNet (Italian Association for Neuroendocrine Tumours) Study Group. Massironi S, et al. Among authors: dotto a. Dig Liver Dis. 2021 Mar;53(3):367-374. doi: 10.1016/j.dld.2020.09.031. Epub 2020 Oct 22. Dig Liver Dis. 2021. PMID: 33645508
Commentary: Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management.
Fanciulli G, Di Molfetta S, Dotto A, Florio T, Feola T, Colao A, Faggiano A; NIKE Group. Fanciulli G, et al. Among authors: dotto a. Front Endocrinol (Lausanne). 2021 Jun 18;12:700806. doi: 10.3389/fendo.2021.700806. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34220723 Free PMC article. No abstract available.
"Present and future of immunotherapy in Neuroendocrine Tumors".
Albertelli M, Dotto A, Nista F, Veresani A, Patti L, Gay S, Sciallero S, Boschetti M, Ferone D. Albertelli M, et al. Among authors: dotto a. Rev Endocr Metab Disord. 2021 Sep;22(3):615-636. doi: 10.1007/s11154-021-09647-z. Epub 2021 Apr 14. Rev Endocr Metab Disord. 2021. PMID: 33851319 Free PMC article. Review.
Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective study.
Albertelli M, Rossi G, Nazzari E, Genova C, Biello F, Rijavec E, Dal Bello MG, Patti L, Tagliamento M, Barletta G, Morabito P, Boschetti M, Dotto A, Campana D, Ferone D, Grossi F. Albertelli M, et al. Among authors: dotto a. J Endocrinol Invest. 2024 Apr 29. doi: 10.1007/s40618-023-02268-0. Online ahead of print. J Endocrinol Invest. 2024. PMID: 38683497
50 results